These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36617511)

  • 41. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
    Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chromone-based benzohydrazide derivatives as potential α-glucosidase inhibitor: Synthesis, biological evaluation and molecular docking study.
    Fan M; Yang W; Peng Z; He Y; Wang G
    Bioorg Chem; 2023 Feb; 131():106276. PubMed ID: 36434950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Towards multi-target antidiabetic agents: In vitro and in vivo evaluation of 3,5-disubstituted indolin-2-one derivatives as novel α-glucosidase inhibitors.
    Klochkov VG; Bezsonova EN; Dubar M; Melekhina DD; Temnov VV; Zaryanova EV; Lozinskaya NA; Babkov DA; Spasov AA
    Bioorg Med Chem Lett; 2022 Jan; 55():128449. PubMed ID: 34780899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel pyridine-2,4,6-tricarbohydrazide thiourea compounds as small key organic molecules for the potential treatment of type-2 diabetes mellitus: In vitro studies against yeast α- and β-glucosidase and in silico molecular modeling.
    Rehman TU; Riaz S; Khan IU; Ashraf M; Bajda M; Gawalska A; Yar M
    Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29194730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of α-glucosidase enzyme along with in silico study.
    Alomari M; Taha M; Rahim F; Selvaraj M; Iqbal N; Chigurupati S; Hussain S; Uddin N; Almandil NB; Nawaz M; Khalid Farooq R; Khan KM
    Bioorg Chem; 2021 Mar; 108():104638. PubMed ID: 33508679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and structure-activity relationship studies of benzimidazole-thioquinoline derivatives as α-glucosidase inhibitors.
    Moghadam Farid S; Noori M; Nazari Montazer M; Khalili Ghomi M; Mollazadeh M; Dastyafteh N; Irajie C; Zomorodian K; Mirfazli SS; Mojtabavi S; Faramarzi MA; Larijani B; Iraji A; Mahdavi M
    Sci Rep; 2023 Mar; 13(1):4392. PubMed ID: 36928433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
    Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, in vitro α-glucosidase inhibitory activity and molecular docking studies of new thiazole derivatives.
    Khan KM; Qurban S; Salar U; Taha M; Hussain S; Perveen S; Hameed A; Ismail NH; Riaz M; Wadood A
    Bioorg Chem; 2016 Oct; 68():245-58. PubMed ID: 27592296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory evaluation of
    Zabidi NA; Ishak NA; Hamid M; Ashari SE; Mohammad Latif MA
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):109-121. PubMed ID: 33249946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
    Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanistic investigation of anthocyanidin derivatives as α-glucosidase inhibitors.
    Kim JH; Kim HY; Jin CH
    Bioorg Chem; 2019 Jun; 87():803-809. PubMed ID: 30978605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors.
    Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.
    Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA
    Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of 1H-1,2,3-triazole derivatives as new α-glucosidase inhibitors and their molecular docking studies.
    Avula SK; Khan A; Rehman NU; Anwar MU; Al-Abri Z; Wadood A; Riaz M; Csuk R; Al-Harrasi A
    Bioorg Chem; 2018 Dec; 81():98-106. PubMed ID: 30118991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
    Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study.
    Abuelizz HA; Anouar EH; Ahmad R; Azman NIIN; Marzouk M; Al-Salahi R
    PLoS One; 2019; 14(8):e0220379. PubMed ID: 31412050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Synthesis, biological activity and molecular docking research of N-{[(4-oxo-thiochroman-3-yl)phenyl]-methyl}acetamide derivatives as α-glucosidase inhibitors].
    Zhou G; Liang GC; Han XY; Zhong YF; Dong YF; Luo XC; Jin HW; Song YL
    Yao Xue Xue Bao; 2016 Jan; 51(1):93-9. PubMed ID: 27405168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
    Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li X; Li J
    Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.